Ixchelsis Ltd

Innovators in Reproductive Health

  • Home
  • About
    • About us
    • Management
    • Directors
    • Investors
  • News
  • Science
    • Premature Ejaculation
    • Oxytocin Receptor Antagonist
  • Contact us
You are here: Home / Science

Science

Definition of Premature Ejaculation (PE)

Research on Oxytocin Antagonist Receptors

Latest News

Ixchelsis Scientific Advisory board AUA Meeting-Boston

May 2017: Members of the Ixchelsis Scientific Advisory Board Present Clinical Results for a Study of IX-01 in Men with PE at American Urological Association Meeting. Boston May 12th -16th 2017

Ixchelsis is pleased to announce that two abstracts relating to the results of the proof of concept trial (PEPIX) of IX-01 in men with lifelong premature ejaculation were accepted … [Read More...]

May 2017: Ixchelsis CEO Gary Muirhead Attended BioTrinity May 08th -10th 2017

Ixchelsis CEO, Gary Muirhead attended BioTrinity in London, May 08-10 2017. Please contact us through the website for further information. … [Read More...]

February 2017: Ixchelsis Announces Start of Phase II B Dose Range-Finding Study for IX-01

Following the positive proof-of-concept data released in 2016, Ixchelsis is pleased to announce the start of the Phase II B dose range-finding study for IX-01 in February 2017. The … [Read More...]

Company Details

IXCHELSIS Ltd
DISCOVERY PARK HOUSE
RAMSGATE ROAD
SANDWICH
KENT
CT13 9NJ
UNITED KINGDOM

Registered in England
Company Registration Number 07719191
VAT Number 171 4965 89


> Website Terms & Conditions
> Privacy Policy

This website uses cookies.
> View our Cookie Policy

Latest News

  • May 2017: Members of the Ixchelsis Scientific Advisory Board Present Clinical Results for a Study of IX-01 in Men with PE at American Urological Association Meeting. Boston May 12th -16th 2017 May 17, 2017
  • May 2017: Ixchelsis CEO Gary Muirhead Attended BioTrinity May 08th -10th 2017 May 3, 2017
  • February 2017: Ixchelsis Announces Start of Phase II B Dose Range-Finding Study for IX-01 March 9, 2017
  • December 2016: Pfizer Ventures and TVM Life Science Ventures VII announce additional investment in Ixchelsis Ltd. January 13, 2017
  • Ixchelsis Ltd announces positive clinical Proof of Concept results for IX-01 in treating premature ejaculation January 28, 2016

Site Map

  • About us
    • Management
    • Directors
    • Investors
  • Science
    • What is Premature Ejaculation
    • Oxytocin Receptor Antagonist
  • Contact us

Return to top of page

Web Site Developed by VinceWEBDESIGN · © 2023 · Ixchelsis Ltd · Admin